drugset
drugset / Trial / NCT01451905

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

NCT01451905 ↗

Unknown 12 enrolled University Hospital, Gentofte, Copenhagen
RandomizedParallel-groupQuadruple-blind

Summary

To examine GLP-1 receptors in skin of psoriasis patients compared with the skin of humans with no skin disease

Timeline

Start
2011-08
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liraglutide Peptide 1.8 mg Subcutaneous

Indications

No indication recorded.